Precigen (PGEN) Goodwill & Intangibles (2012 - 2026)
Precigen's (PGEN) quarterly Goodwill & Intangibles came in at $18.1 million in Q1 2026, down 22.25% year-on-year from $23.3 million in Q1 2025, and down 1.73% on a QoQ basis from $18.4 million in Q4 2025.
Precigen (PGEN) Goodwill & Intangibles (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Goodwill & Intangibles data on file, last reported at $18.1 million in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 22.25% year-over-year to $18.1 million in Q1 2026; TTM through Mar 2026 was $18.1 million, a 22.25% decrease from a year earlier, with the FY2025 full-year figure at $18.4 million, down 21.95% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $18.1 million, down from $18.4 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for PGEN reached as high as $105.0 million in Q1 2022 and fell as low as $18.1 million in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $52.9 million across 5 years, with a median of $65.3 million in 2024.
- Across the five-year window, Goodwill & Intangibles dropped 2.29% in 2023 and tumbled 64.95% in 2024, its largest moves.
- Year by year, Goodwill & Intangibles stood at $81.4 million in 2022, then fell by 17.28% to $67.3 million in 2023, then tumbled by 64.95% to $23.6 million in 2024, then declined by 21.95% to $18.4 million in 2025, then declined by 1.73% to $18.1 million in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $18.1 million in Q1 2026, $18.4 million in Q4 2025, and $18.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | Precigen | 2.00 Bn | 2.00 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.10 Mn |
| Dec 31, 2025 | 18.41 Mn |
| Sep 30, 2025 | 18.73 Mn |
| Jun 30, 2025 | 19.05 Mn |
| Mar 31, 2025 | 23.28 Mn |
| Dec 31, 2024 | 23.59 Mn |
| Sep 30, 2024 | 29.69 Mn |
| Jun 30, 2024 | 30.01 Mn |
| Mar 31, 2024 | 65.27 Mn |
| Dec 31, 2023 | 67.31 Mn |
| Sep 30, 2023 | 77.32 Mn |
| Jun 30, 2023 | 79.62 Mn |
| Mar 31, 2023 | 80.81 Mn |
| Dec 31, 2022 | 81.38 Mn |
| Sep 30, 2022 | 79.13 Mn |
| Jun 30, 2022 | 82.80 Mn |
| Mar 31, 2022 | 105.04 Mn |
| Dec 31, 2021 | 89.85 Mn |
| Sep 30, 2021 | 111.12 Mn |
| Jun 30, 2021 | 114.22 Mn |